Metastatic CRPC: Advent of PARP Inhibitors
Comprehensive insight on the evolving role of PARP inhibitors in metastatic castration-resistant prostate cancer and clinical trials in this setting.
Source: onclive.com
Stay updated with breaking news from Propel Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Comprehensive insight on the evolving role of PARP inhibitors in metastatic castration-resistant prostate cancer and clinical trials in this setting.
A scientist from University of Rhode Island will investigate a surprise chemical reaction that might be beneficial in releasing hydrogen for fuel cells courtesy of an Early Career Award from the U.S. Department of Energy.